Skip to main content
. 2021 Feb 28;10(3):517. doi: 10.3390/cells10030517

Figure 6.

Figure 6

DSF induced the growth inhibition in HNSCC-derived patient-derived tumor xenograft (PDX) models. Three independently derived permanently growing PDX models from a primary HNSCC tumor were transplanted onto severe combined immune deficiency (SCID) mice and single animals, each treated by DSF, cisplatin, or a combination. Tumor volumes were measured twice a week.